Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W van den Berg

Showing results (41-50 of 353) with videos related to

Pageof 36
Sort By:
The Netherlands Journal of Surgery|February 1, 1986
Progressive pneumoperitoneum as preoperative preparation for large hernial repair in patients with severe chronic obstructive lung diseaseP N Rieu, L A van Knippenberg, W van den Berg
Journal of Immunological Methods|October 19, 1990
Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse systemC W Van den Berg, P C Aerts, H Van Dijk
Arteriosclerosis, Thrombosis, and Vascular Biology|April 2, 2005
C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharideKarolina E Taylor, John C Giddings, Carmen W van den Berg
Journal of Immunological Methods|February 15, 1991
In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja hajeC W Van den Berg, P C Aerts, H Van Dijk
Cancer Letters|February 6, 1996
Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitroD McCotter, H W van den Berg, M Boylan, et al.
Molecular Immunology|August 10, 2010
Binding of human antigen R (HuR) to an AU-rich element (ARE) in the 3'untranslated region (3'UTR) reduces the expression of decay accelerating factor (DAF)Lisa C Gray, Timothy R Hughes, Carmen W van den Berg
Journal of Chromatography|February 7, 1992
Rapid isolation of human complement component C9 to verify the specificity of a haemolytic C9 microassayH J Bootsma, C W van den Berg, H van Dijk
Molecular Immunology|March 7, 2006
Characterisation of the complement susceptibility of the rat aortic smooth muscle cell line A7r5Steven Capey, James G Q Mosedale, Carmen W van den Berg
BMC Public Health|July 23, 2013
Changes in school environment, awareness and actions regarding overweight prevention among Dutch secondary schools between 2006-2007 and 2010-2011Saskia W van den Berg, Jochen Mikolajczak, Wanda J E Bemelmans
Immunology|April 1, 1997
Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrestK J Marchbank, C W van den Berg, B P Morgan
Pageof 36

Showing results (41-50 of 353) with videos related to

Sort By:
Pageof 36
The Netherlands Journal of Surgery|February 1, 1986
Progressive pneumoperitoneum as preoperative preparation for large hernial repair in patients with severe chronic obstructive lung diseaseP N Rieu, L A van Knippenberg, W van den Berg
Journal of Immunological Methods|October 19, 1990
Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse systemC W Van den Berg, P C Aerts, H Van Dijk
Arteriosclerosis, Thrombosis, and Vascular Biology|April 2, 2005
C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharideKarolina E Taylor, John C Giddings, Carmen W van den Berg
Journal of Immunological Methods|February 15, 1991
In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja hajeC W Van den Berg, P C Aerts, H Van Dijk
Cancer Letters|February 6, 1996
Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitroD McCotter, H W van den Berg, M Boylan, et al.
Molecular Immunology|August 10, 2010
Binding of human antigen R (HuR) to an AU-rich element (ARE) in the 3'untranslated region (3'UTR) reduces the expression of decay accelerating factor (DAF)Lisa C Gray, Timothy R Hughes, Carmen W van den Berg
Journal of Chromatography|February 7, 1992
Rapid isolation of human complement component C9 to verify the specificity of a haemolytic C9 microassayH J Bootsma, C W van den Berg, H van Dijk
Molecular Immunology|March 7, 2006
Characterisation of the complement susceptibility of the rat aortic smooth muscle cell line A7r5Steven Capey, James G Q Mosedale, Carmen W van den Berg
BMC Public Health|July 23, 2013
Changes in school environment, awareness and actions regarding overweight prevention among Dutch secondary schools between 2006-2007 and 2010-2011Saskia W van den Berg, Jochen Mikolajczak, Wanda J E Bemelmans
Immunology|April 1, 1997
Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrestK J Marchbank, C W van den Berg, B P Morgan
Pageof 36